Literature DB >> 15486466

Apolipoprotein E-induced cell signaling in the vessel wall.

David Y Hui1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15486466     DOI： 10.1023/B:REMD.0000045105.26290.2d

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  53 in total

1.  Identification of a major cyclic AMP-dependent protein kinase A phosphorylation site within the cytoplasmic tail of the low-density lipoprotein receptor-related protein: implication for receptor-mediated endocytosis.

Authors:  Y Li; P van Kerkhof ; M P Marzolo; G J Strous; G Bu
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  Essential role of the low density lipoprotein receptor-related protein in vascular smooth muscle cell migration.

Authors:  Yonghe Li; Wenyan Lu; Guojun Bu
Journal:  FEBS Lett       Date:  2003-12-04       Impact factor: 4.124

Review 3.  Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E.

Authors:  R W Mahley; Z S Ji
Journal:  J Lipid Res       Date:  1999-01       Impact factor: 5.922

4.  Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cells.

Authors:  Sandra M Sacre; Anita K Stannard; James S Owen
Journal:  FEBS Lett       Date:  2003-04-10       Impact factor: 4.124

5.  Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse.

Authors:  Y Nakashima; E W Raines; A S Plump; J L Breslow; R Ross
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-05       Impact factor: 8.311

6.  Localization of apolipoprotein E receptor 2 to caveolae in the plasma membrane.

Authors:  D R Riddell; X M Sun; A K Stannard; A K Soutar; J S Owen
Journal:  J Lipid Res       Date:  2001-06       Impact factor: 5.922

7.  Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease.

Authors:  D R Riddell; A Graham; J S Owen
Journal:  J Biol Chem       Date:  1997-01-03       Impact factor: 5.157

8.  ApoE-dependent sterol efflux from macrophages is modulated by scavenger receptor class B type I expression.

Authors:  Zhi Hua Huang; Theodore Mazzone
Journal:  J Lipid Res       Date:  2002-03       Impact factor: 5.922

9.  Low-density-lipoprotein-receptor-related protein (LRP) interacts with a GTP-binding protein.

Authors:  L Goretzki; B M Mueller
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

10.  Vascular apolipoprotein e expression and recruitment from circulation to modulate smooth muscle cell response to endothelial denudation.

Authors:  Zachary W Q Moore; Binghua Zhu; David G Kuhel; David Y Hui
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307
View more
  3 in total

1.  Apolipoprotein E favours the blunting by high-fat diet of prostacyclin receptor activation in the mouse aorta.

Authors:  Yanhua Cheng; Paul M Vanhoutte; Susan W S Leung
Journal:  Br J Pharmacol       Date:  2018-07-22       Impact factor: 8.739

2.  The relative atherogenicity of VLDL and LDL is dependent on the topographic site.

Authors:  Eline Van Craeyveld; Frank Jacobs; Yingmei Feng; Leen C J Thomassen; Johan A Martens; Joke Lievens; Jan Snoeys; Bart De Geest
Journal:  J Lipid Res       Date:  2010-01-19       Impact factor: 5.922

3.  Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH(2).

Authors:  Geeta Datta; C Roger White; Nassrin Dashti; Manjula Chaddha; Mayakonda N Palgunachari; Himanshu Gupta; Shaila P Handattu; David W Garber; G M Anantharamaiah
Journal:  Atherosclerosis       Date:  2009-07-15       Impact factor: 5.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.